About Johann Proeve, Chief Scientific Officer

Dr Johann Proeve, our Chief Scientific Officer, has over thirty five years of experience working across the Pharma CRO industry, being the former Head of Global Data Management at Bayer AG.
Feb 2018

Adaptive Monitoring: The First Implementation Steps in Real-Life

By | 2018-02-14T07:20:49+00:00 February 13, 2018|Blog, Case Study|0 Comments

It is widely broadcasted that pharma companies will have to accelerate adoption of adaptive clinical trial designs to reduce study timelines and costs while increasing success rates. Risk-based Monitoring “Real RBM” integrates the Adaptive Monitoring (AM) process, which addresses all aspects of Quality Risk Management.

Register Today!

Get Free Test Access